Page last updated: 2024-09-03

4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol and Clinically Isolated CNS Demyelinating Syndrome

4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dreyfus, CF; Fulmer, CG; Hempstead, BL; Huang, Y; Stillman, AA; VonDran, MW1

Other Studies

1 other study(ies) available for 4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol and Clinically Isolated CNS Demyelinating Syndrome

ArticleYear
Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014, Jun-11, Volume: 34, Issue:24

    Topics: Animals; Astrocytes; Brain-Derived Neurotrophic Factor; Cuprizone; Demyelinating Diseases; Dioxolanes; Disease Models, Animal; Estrogen Antagonists; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myelin Proteins; Purines; Receptors, Metabotropic Glutamate; RNA, Untranslated; Signal Transduction; Tamoxifen

2014